Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 153829, 9 pages
http://dx.doi.org/10.1155/2015/153829
Research Article

Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes

1Discipline of Biotechnology, School of Medicine, Flinders University, Bedford Park, SA 5042, Australia
2Discipline of Surgery, School of Medicine, Flinders University, Bedford Park, SA 5042, Australia
3Discipline of Haematology, School of Medicine, Flinders University, Bedford Park, SA 5042, Australia
4Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
5Discipline of Human Physiology, School of Medicine, Flinders University, Bedford Park, SA 5042, Australia

Received 6 May 2015; Revised 20 July 2015; Accepted 26 July 2015

Academic Editor: Raffaele Marfella

Copyright © 2015 Samira Tajbakhsh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Winer and J. R. Sowers, “Epidemiology of diabetes,” Journal of Clinical Pharmacology, vol. 44, no. 4, pp. 397–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. R. Preis, M. J. Pencina, S.-J. Hwang et al., “Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study,” Circulation, vol. 120, no. 3, pp. 212–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Ding and C. R. Triggle, “Endothelial dysfunction in diabetes: multiple targets for treatment,” Pflugers Archiv European Journal of Physiology, vol. 459, no. 6, pp. 977–994, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Miller, K. Budzyn, and C. G. Sobey, “Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention,” Clinical Science, vol. 119, no. 1, pp. 1–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Tajbakhsh and E. M. Sokoya, “Regulation of cerebral vascular function by sirtuin 1,” Microcirculation, vol. 19, no. 4, pp. 336–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Mattagajasingh, C.-S. Kim, A. Naqvi et al., “SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 37, pp. 14855–14860, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Olmos, I. Valle, S. Borniquel et al., “Mutual dependence of Foxo3a and PGC-1α in the induction of oxidative stress genes,” Journal of Biological Chemistry, vol. 284, no. 21, pp. 14476–14484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. V. De Kreutzenberg, G. Ceolotto, I. Papparella et al., “Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms,” Diabetes, vol. 59, no. 4, pp. 1006–1015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-R. Chen, S.-R. Fang, Y.-C. Fu, X.-H. Zhou, M.-Y. Xu, and W.-C. Xu, “Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats.,” Biochemistry and Cell Biology, vol. 88, no. 4, pp. 715–722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Q.-J. Zhang, Z. Wang, H.-Z. Chen et al., “Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice,” Cardiovascular Research, vol. 80, no. 2, pp. 191–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Tajbakhsh and E. M. Sokoya, “Sirtuin 1 is upregulated in young obese Zucker rat cerebral arteries,” European Journal of Pharmacology, vol. 721, no. 1–3, pp. 43–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Palacios, D. Herranz, M. L. De Bonis, S. Velasco, M. Serrano, and M. A. Blasco, “SIRT1 contributes to telomere maintenance and augments global homologous recombination,” The Journal of Cell Biology, vol. 191, no. 7, pp. 1299–1313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Blasco, “The epigenetic regulation of mammalian telomeres,” Nature Reviews Genetics, vol. 8, no. 4, pp. 299–309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C.-Y. Wang, H.-H. Kim, Y. Hiroi et al., “Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR,” Science Signaling, vol. 2, no. 62, article ra11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. von Zglinicki, “Oxidative stress shortens telomeres,” Trends in Biochemical Sciences, vol. 27, no. 7, pp. 339–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Y. L. Zee, A. J. Castonguay, N. S. Barton, S. Germer, and M. Martin, “Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study,” Translational Research, vol. 155, no. 4, pp. 166–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Murillo-Ortiz, F. Albarrán-Tamayo, D. Arenas-Aranda et al., “Telomere length and type 2 diabetes in males, a premature aging syndrome,” Aging Male, vol. 15, no. 1, pp. 54–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Tajbakhsh and E. M. Sokoya, “Compromised endothelium-dependent hyperpolarization-mediated dilations can be rescued by NS309 in obese Zucker rats,” Microcirculation, vol. 21, no. 8, pp. 747–753, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. D. Colella, N. Chegenii, M. N. Tea, I. L. Gibbins, K. A. Williams, and T. K. Chataway, “Comparison of Stain-Free gels with traditional immunoblot loading control methodology,” Analytical Biochemistry, vol. 430, no. 2, pp. 108–110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Cawthon, “Telomere measurement by quantitative PCR,” Nucleic Acids Research, vol. 30, no. 10, article e47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. R. M. Cawthon, “Telomere length measurement by a novel monochrome multiplex quantitative PCR method,” Nucleic Acids Research, vol. 37, no. 3, article e21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. L. da Luz, L. Tanaka, P. C. Brum et al., “Red wine and equivalent oral pharmacological doses of resveratrol delay vascular aging but do not extend life span in rats,” Atherosclerosis, vol. 224, no. 1, pp. 136–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. R. Raymond, B. Hodson, A. J. Woodiwiss, G. R. Norton, and R. L. Brooksbank, “Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats,” European Journal of Applied Physiology, vol. 113, no. 11, pp. 2803–2811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. D.-C. Lee, J.-A. Im, J.-H. Kim, H.-R. Lee, and J.-Y. Shim, “Effect of long-term hormone therapy on telomere length in postmenopausal women,” Yonsei Medical Journal, vol. 46, no. 4, pp. 471–479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Orimo, T. Minamino, H. Miyauchi, K. Tateno, S. Okada, and I. Komuro, “Protective role of SIRT1 in diabetic vascular dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 6, pp. 889–894, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Matsui-Hirai, T. Hayashi, S. Yamamoto et al., “Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide,” Journal of Pharmacology and Experimental Therapeutics, vol. 337, no. 3, pp. 591–599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. P. Davidson, L. J. Coppey, N. A. Calcutt, C. L. Oltman, and M. A. Yorek, “Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 4, pp. 306–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H. E. Lebovitz and M. A. Banerji, “Treatment of insulin resistance in diabetes mellitus,” European Journal of Pharmacology, vol. 490, no. 1–3, pp. 135–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. G. M. Reaven, C. Hollenbeck, C.-Y. Jeng, M. S. Wu, and Y.-D. I. Chen, “Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM,” Diabetes, vol. 37, no. 8, pp. 1020–1024, 1988. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Boden, “Role of fatty acids in the pathogenesis of insulin resistance and NIDDM,” Diabetes, vol. 46, no. 1, pp. 3–10, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Y. Donath and S. E. Shoelson, “Type 2 diabetes as an inflammatory disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 98–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Adaikalakoteswari, M. Balasubramanyam, and V. Mohan, “Telomere shortening occurs in Asian Indian Type 2 diabetic patients,” Diabetic Medicine, vol. 22, no. 9, pp. 1151–1156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. K. D. Salpea, P. J. Talmud, J. A. Cooper et al., “Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation,” Atherosclerosis, vol. 209, no. 1, pp. 42–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Olivieri, M. Lorenzi, R. Antonicelli et al., “Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction,” Atherosclerosis, vol. 206, no. 2, pp. 588–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Testa, F. Olivieri, C. Sirolla et al., “Leukocyte telomere length is associated with complications of type 2 diabetes mellitus,” Diabetic Medicine, vol. 28, no. 11, pp. 1388–1394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Tentolouris, R. Nzietchueng, V. Cattan et al., “White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria,” Diabetes Care, vol. 30, no. 11, pp. 2909–2915, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Ogami, Y. Ikura, M. Ohsawa et al., “Telomere shortening in human coronary artery diseases,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 546–550, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Matthews, I. Gorenne, S. Scott et al., “Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress,” Circulation Research, vol. 99, no. 2, pp. 156–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. W. R. W. Wilson, K. E. Herbert, Y. Mistry et al., “Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease,” European Heart Journal, vol. 29, no. 21, pp. 2689–2694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Fyhrquist and O. Saijonmaa, “Telomere length and cardiovascular aging,” Annals of Medicine, vol. 44, supplement 1, pp. S138–S142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. L. De Bonis, S. Ortega, and M. A. Blasco, “SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells,” Stem Cell Reports, vol. 2, no. 5, pp. 690–706, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Cipolla, Integrated Systems Physiology: From Molecule to Function, Morgan & Claypool Life Sciences, San Rafael, Calif, USA, 2009.
  45. M. L. Balestrieri, M. Rienzo, F. Felice et al., “High glucose downregulates endothelial progenitor cell number via SIRT1,” Biochimica et Biophysica Acta, vol. 1784, no. 6, pp. 936–945, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Shao, J. L. Fry, J. Han et al., “A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress,” The Journal of Biological Chemistry, vol. 289, no. 11, pp. 7293–7306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. J. You, T. D. Johnson, W. F. Childres, and R. M. Bryan Jr., “Endothelial-mediated dilations of rat middle cerebral arteries by ATP and ADP,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 273, no. 3, pp. H1472–H1477, 1997. View at Google Scholar · View at Scopus
  48. S. K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, and I. Jialal, “Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells,” Circulation, vol. 106, no. 12, pp. 1439–1441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Federici, R. Menghini, A. Mauriello et al., “Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells,” Circulation, vol. 106, no. 4, pp. 466–472, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. E. P. Davidson, L. J. Coppey, B. Dake, and M. A. Yorek, “Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications,” Experimental Diabetes Research, vol. 2011, Article ID 810469, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. C. K. Roberts, R. J. Barnard, R. K. Sindhu, M. Jurczak, A. Ehdaie, and N. D. Vaziri, “Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome,” Metabolism: Clinical and Experimental, vol. 55, no. 7, pp. 928–934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Giorgio, E. Migliaccio, F. Orsini et al., “Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis,” Cell, vol. 122, no. 2, pp. 221–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Miyazawa and Y. Tsuji, “Evidence for a novel antioxidant function and isoform-specific regulation of the human p66Shc gene,” Molecular Biology of the Cell, vol. 25, no. 13, pp. 2116–2127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. C. D. Morrison, P. J. Pistell, D. K. Ingram et al., “High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: Implications for decreased Nrf2 signaling,” Journal of Neurochemistry, vol. 114, no. 6, pp. 1581–1589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Lassègue and K. K. Griendling, “NADPH oxidases: functions and pathologies in the vasculature,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 653–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. C. M. Lynch, D. A. Kinzenbaw, X. Chen et al., “Nox2-derived superoxide contributes to cerebral vascular dysfunction in diet-induced Obesity,” Stroke, vol. 44, no. 11, pp. 3195–3201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Zhu, B. Liu, W. Luo et al., “Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 307, no. 3, pp. H319–H327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. M. E. Inkster, M. A. Cotter, and N. E. Cameron, “Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats,” European Journal of Pharmacology, vol. 561, no. 1–3, pp. 63–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Molnar, S. Yu, N. Mzhavia, C. Pau, I. Chereshnev, and H. M. Dansky, “Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice,” Circulation Research, vol. 96, no. 11, pp. 1178–1184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Bourgoin, H. Bachelard, M. Badeau et al., “Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 295, no. 3, pp. H1044–H1055, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. O. Galili, D. Versari, K. J. Sattler et al., “Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 2, pp. H904–H911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. E. P. Davidson, T. L. Kleinschmidt, C. L. Oltman, D. D. Lund, and M. A. Yorek, “Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease,” Diabetes, vol. 56, no. 2, pp. 355–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. M. T. Hemann, M. A. Strong, L.-Y. Hao, and C. W. Greider, “The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability,” Cell, vol. 107, no. 1, pp. 67–77, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Canela, E. Vera, P. Klatt, and M. A. Blasco, “High-throughput telomere length quantification by FISH and its application to human population studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 13, pp. 5300–5305, 2007. View at Publisher · View at Google Scholar · View at Scopus